The Inspire Sleep Apnea Implant is really a medical device that’s implanted in to the body for the treatment of snoring and obstructive sleep apnea (OSA) syndrome.
Obstructive Sleep Apnea Syndrome
Obstructive sleep apnea syndrome is really a disease caused by relapsing episodes of anti snoring. This can be a condition where breathing stops for more than 10 seconds, during which oxygen saturation in the blood is reduced by a lot more than 4%.
OSA syndrome occurs during sleep, once the muscles of upper airways relax, causing the obstruction of the respiratory tract. This leads to deterioration of blood oxygenation and provokes short unconscious wake-up episodes throughout the night. An unhealthy pattern of sleep places pressure on the body, causing increased blood circulation pressure and development of severe diseases. The diseases due to OSA can be physical, such as for example hypertension, myocardium infarction and stroke. They could also be mental, including depression, chronic fatigue syndrome, lack of memory and concentration.
Before any treatment, a sleep study or perhaps a polysomnography is necessary. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during 1 hour of sleep and determines the severity of the condition. The apnea index is known as significant if you can find a lot more than 20 apnea episodes per hour, whatever the presence or lack of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy isn’t for everyone as many people think it is uncomfortable to sleep with the mask on the face and the device itself can be loud, especially since it commonly sits near the head. Only 25% of patients may use CPAP-therapy for an extended period of time.
Therefore, recently Inspire Medical Systems Inc. has think of a very effective solution with the Inspire ANTI SNORING Implant.
How The Inspire Sleep Apnea Implant Works
The Inspire ANTI SNORING Implant is really a battery operated device that promotes electrostimulation of the sublingual nerve. ufa The battery life is approximately 10 years.
The main unit of the device is placed under the skin, on the front right side of the chest and it monitors the phase of breathing. Another electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens the upper airways and allows the tongue to stick out, and helps keep the airways open during sleep.
As well as the two electrodes, this device also includes a handy small remote switch, which actually turns on the device before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating during the active phase of the day, when a person needs physiological narrowing of the larynx and tongue movements for these processes.
The patient may feel light involuntary contractions of the larynx, or tongue movements during initial use of the device. These movements do not cause pain, instead just a minor discomfort. These unpleasant effects disappear after the first few uses of the device.
Generally, the implant should be checked one or two 2 times per year. However, according to the situation, an Inspire therapy-trained doctor may consult patients pretty much often.
The Inspire ANTI SNORING Implant is only ideal for:
Patients who are more than 22 years old.
Patients who have been identified as having moderate or severe obstructive sleep apnea syndrome.
Patients having an apnea index in the range of 20 to 65.
Patients who are uncomfortable with using CPAP therapy or didn’t have the desired effect.
Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
An individual with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire ANTI SNORING Implant could potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive sleep apnea syndrome. A study by Dr. Ryan J. et al. shows that after implantation of the Inspire ANTI SNORING Implant, snoring is greatly decreased. A share of “no” or “soft” snoring changed from 22% at beginning of the treatment to 88% at 12 months and 91% at two years after the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the analysis reported a nightly use of this therapy for five years. Therefore, it really is evident that this method is impressive and simple to use!